In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci

被引:16
|
作者
Fluit, AC [1 ]
Schmitz, FJ [1 ]
Verhoef, J [1 ]
Milatovic, D [1 ]
机构
[1] UMCU, Eijkman Winkler Ctr, NL-3508 GA Utrecht, Netherlands
关键词
D O I
10.1093/jac/dkf109
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
AZD2563 is a new oxazolidinone that has targeted activity against Gram-positive bacteria. The in vitro activity of AZD2563 and nine comparators against 1543 European enterococcal, staphylococcal and streptococcal isolates was determined. The compound is a potent oxazolidinone, with no isolate tested displaying an MIC > 4 mg/L and 94.4% having an MIC less than or equal to2 mg/L. Compared with linezolid, the distribution of MICs for all species of bacteria tested, with the exception of Enterococcus faecium, was shifted by one or two dilution steps to lower values for AZD2563. Thus, this oxazolidinone is a promising new antibiotic for the treatment of infections with Gram-positive cocci.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 50 条
  • [41] In vitro activity of novel rifamycins against gram-positive clinical isolates
    Murphy, Christopher K.
    Karginova, Elena
    Sahm, Dan
    Rothstein, David M.
    JOURNAL OF ANTIBIOTICS, 2007, 60 (09): : 572 - 576
  • [42] Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci
    Tsao, Shih-Ming
    Lin, Hsiu-Chen
    Lee, Chun-Ming
    Hsu, Gwo-Jong
    Chen, Chih-Ming
    Sun, Wu
    Liu, Yung-Ching
    Jang, Tsrang-Neng
    Cheng, Yu-Jen
    Lu, Po-Liang
    Chiang, Ping-Chreng
    Wang, Lih-Shinn
    Kung, Hsiang-Chi
    Chuang, Yin-Ching
    Shi, Zhi-Yuan
    Liu, Jien-Wei
    Huang, Cheng-Hua
    Lu, Chin-Te
    Liao, Chun-Hsing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S184 - S187
  • [43] Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci
    Ravaoarinoro, M
    Therrien, C
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (03) : 167 - 170
  • [44] Copper activity against multiresistant Gram-positive cocci isolated in Chilean hospitals
    Kappes, Tomas
    Dominguez, Mariana
    Bello-Toledo, Helia
    Montecinos, Sergio Melia
    Molina, Gisella Riedel
    Gonzalez-Rocha, Gerardo
    REVISTA CHILENA DE INFECTOLOGIA, 2016, 33 (05): : 519 - 523
  • [45] COMPARISON OF THE INVITRO ANTIBACTERIAL ACTIVITY OF TEICOPLANIN AND VANCOMYCIN AGAINST GRAM-POSITIVE COCCI
    RAVIZZOLA, G
    PIRALI, F
    FORESTI, I
    TURANO, A
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1987, 13 (04) : 225 - 229
  • [46] Activity of linezolid against Gram-positive cocci: a multicentre study in Greek hospitals
    Pratti, A.
    Karanika, M.
    Maniatis, A. N.
    Petinaki, E.
    Spiliopoulou, I.
    Kolonitsiou, F.
    Tatsiopoulos, A.
    Alexiou-Daniel, S.
    Bakola, D.
    Koutsia-Carousou, Ch.
    Malamou-Lada, H.
    Siafakas, N.
    Zerva, L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (05) : 604 - 605
  • [48] In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci
    Noviello, S
    Ianniello, F
    Esposito, S
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) : 283 - 286
  • [49] Gram-positive cocci multiresistant to antibiotics: activity of linezolid
    Leclercq, R
    MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (09): : 449 - 459
  • [50] Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci
    Jones, Ronald N.
    Fritsche, Thomas R.
    Sader, Helio S.
    Ross, James E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2583 - 2586